Corestem Patents

Patent portfolio assigned to Corestem (verified via public assignee records). Korean stem-cell biotech (now CorestemChemon); lead product NeuroNata-R/Lenzumestrocel for ALS. Patents confirmed under assignee 'Corestem Co., Ltd.' (US8277795B2, US8951511B2). Biotech - no commercial customers.